A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.
Saved in:
| Title: | A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD. |
|---|---|
| Authors: | Wells JA, Gonzales CR, Berger BB, Gonzalez VH, Sippy BD, Burian G |
| Source: | Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2018 May 01; Vol. 49 (5), pp. 336-345. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
